Hepatitis B, a disease that seems distant but close at hand. According to the World Health Organization, there are about 2There are 5.7 billion people infected with hepatitis B virus, and China is a big country with hepatitis B, and hepatitis B has brought a heavy burden to countless patients and families.
However, hepatitis B is not invincible, with the advancement of science and technology and the development of medicine, more and more hepatitis B patients have achieved stability or even stability through standardized and self-management.
Recently,Chief Physician Chen Xiaorong, Director of the Department of Traditional Chinese Medicine of Shanghai Public Health Clinical CenterAs a guest in the live broadcast room of "Dialogue with Famous Doctor Lin Xin" of the Medical Federation, a live broadcast with the theme of "Bispecific Antibodies**, Let Hepatitis B Patients Benefit More!".The live broadcast together with the related issues of hepatitis B bispecific antibody that netizens are concerned about.
What are the "bispecific antibodies" for hepatitis B**
What is the "bispecific antibody"** for hepatitis B:On the basis of antiviral**, combined with antifibrotic drugs** hepatitis B
Hepatitis B is a liver disease caused by the hepatitis B virus, and antiviral** is the key to hepatitis B**. Antiviral drugs can inhibit viral replication and reduce inflammation and fibrosis in the liver.
However, antiviral** does not completely stop the progression of liver fibrosis. Therefore, for some patients who have developed liver fibrosis, doctors may recommend a combination of antifibrotic drugs in addition to antiviral** to slow or reverse the progression of liver fibrosis.
"The combination of antiviral and antifibrotic methods can better control the disease and protect liver function for hepatitis B patients, so as to achieve better results to reduce the risk of liver cirrhosis and liver cancer. Director Chen Xiaorong mentioned.
"Hepatitis B-cirrhosis-liver cancer", do the three stages need to continue "bispecific antibodies"**?
The hepatitis B trilogy is a process of gradual deterioration of hepatitis B's condition, and whether it is necessary to continue "bispecific antibodies**" at different stages needs to be judged on a case-by-case basis. In this regard,Director Chen Xiaorong introduced
In the hepatitis B stage, if the patient has a high viral load and abnormal liver function, antiviral** is indicated. Antiviral** can inhibit viral replication, reduce liver inflammation, and reduce the risk of cirrhosis and liver cancer. At the same time, antifibrosis** is also required for patients who have developed liver fibrosis to slow or stop the progression of liver fibrosis.
In the cirrhosis phase, antiviral** remainsNecessary, which can slow or stop the progression of cirrhosis and reduce the risk of liver cancer. At the same time, for patients who have developed complications such as portal hypertension and ascites, corresponding ** is also needed to alleviate symptoms and improve quality of life.
In the liver cancer stage, the antiviral effect is relatively small, but it can still play a certain role in some patients. At the same time, for liver cancer patients, a comprehensive ** is required, including surgery, radiotherapy, chemotherapy, etc., to improve the ** effect.
Traditional Chinese medicine ** liver fibrosis has significant advantages!
Some studies have shown that certain herbs can passRegulates the immune function of the liverInhibits the inflammatory response of the liverReduces collagen synthesis and depositionand so on, thereby reducing the degree of liver fibrosis. For example,Turtle shell, peach kernel, salvia, astragalus, angelicaand other traditional Chinese medicines have a certain anti-liver fibrosis effect.
Compared with Western medicine, traditional Chinese medicine often contains a variety of active ingredients and can act on multiple targets, thus playing a comprehensive roleAnd the *** of traditional Chinese medicine is often smaller, and the burden on the liver is relatively small.
Director Chen Xiaorong reminded everyone: "It should be noted that the use of traditional Chinese medicine needs to be individualized according to the specific situation of the patient, and cannot be generalized. ”
All in all, once hepatitis B patients are diagnosed, they should be treated as soon as possible to protect liver function, improve quality of life, and reduce the risk of disease100 help plan